secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirion Technologies, Inc. (MIR)
CIK:        0001809987
Form:       8-K
Filed at:   2022-09-19T23:59:59+00:00
Accession:  0001628280-22-025095
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mirion appoints Dr. Sheila Rege to board, replacing Warren
----------------------------------------------------------

- Christopher Warren resigned from Mirion's Board effective Sept 16, 2022; departure not due to any disagreement.
- Dr. Sheila Rege appointed to Board effective Sept 16, 2022, filling Warren's vacancy; will stand for reelection in 2023.
- Dr. Rege is a board-certified radiation oncologist, CEO/Founder of Northwest Cancer Clinic, with 30+ years in nuclear medicine.
- Chairman L.D. Kingsley cited goal to grow Medical segment to at least 50% of total company revenue.
- Dr. Rege will receive standard non-employee director compensation and serve on Audit and Compensation Committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809987/000162828022025095/0001628280-22-025095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809987/000162828022025095/mir-20220913.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-025095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer